Cargando…

Second-generation compound for the modulation of utrophin in the therapy of DMD

Duchenne muscular dystrophy (DMD) is a lethal, X-linked muscle-wasting disease caused by lack of the cytoskeletal protein dystrophin. There is currently no cure for DMD although various promising approaches are progressing through human clinical trials. By pharmacologically modulating the expression...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guiraud, Simon, Squire, Sarah E., Edwards, Benjamin, Chen, Huijia, Burns, David T., Shah, Nandini, Babbs, Arran, Davies, Stephen G., Wynne, Graham M., Russell, Angela J., Elsey, David, Wilson, Francis X., Tinsley, Jon M., Davies, Kay E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492389/ https://www.ncbi.nlm.nih.gov/pubmed/25935002 http://dx.doi.org/10.1093/hmg/ddv154

Ejemplares similares

Identification of serum protein biomarkers for utrophin based DMD therapy
por: Guiraud, Simon, et al.
Publicado: (2017)

Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD
por: Guiraud, Simon, et al.
Publicado: (2019)

The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy
por: Guiraud, Simon, et al.
Publicado: (2019)

Micro-utrophin Improves Cardiac and Skeletal Muscle Function of Severely Affected D2/mdx Mice
por: Kennedy, Tahnee L., et al.
Publicado: (2018)

Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle
por: Kennedy, Tahnee L., et al.
Publicado: (2017)

Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping
por: Goyenvalle, Aurélie, et al.
Publicado: (2012)

Safety, tolerability, and pharmacokinetics of SMT C1100, a 2‐arylbenzoxazole utrophin modulator, following single‐ and multiple‐dose administration to healthy male adult volunteers
por: Tinsley, Jon, et al.
Publicado: (2015)

Chemical Proteomics and Phenotypic Profiling Identifies the Aryl Hydrocarbon Receptor as a Molecular Target of the Utrophin Modulator Ezutromid
por: Wilkinson, Isabel V. L., et al.
Publicado: (2020)

From diagnosis to therapy in Duchenne muscular dystrophy
por: Babbs, Arran, et al.
Publicado: (2020)

Synthesis of SMT022357 enantiomers and in vivo evaluation in a Duchenne muscular dystrophy mouse model
por: Babbs, Arran, et al.
Publicado: (2020)

Postsynaptic Abnormalities at the Neuromuscular Junctions of Utrophin-deficient Mice
por: Deconinck, Anne E., et al.
Publicado: (1997)

Advances in genetic therapeutic strategies for Duchenne muscular dystrophy
por: Guiraud, Simon, et al.
Publicado: (2015)

Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies
por: Janghra, Narinder, et al.
Publicado: (2016)

High-throughput identification of post-transcriptional utrophin up-regulators for Duchenne muscle dystrophy (DMD) therapy
por: Loro, Emanuele, et al.
Publicado: (2020)

Daily Treatment with SMTC1100, a Novel Small Molecule Utrophin Upregulator, Dramatically Reduces the Dystrophic Symptoms in the mdx Mouse
por: Tinsley, Jonathon M., et al.
Publicado: (2011)

Author Correction: High-throughput identification of post-transcriptional utrophin up-regulators for Duchenne muscle dystrophy (DMD) therapy
por: Loro, Emanuele, et al.
Publicado: (2020)

Sertoli Cells Improve Myogenic Differentiation, Reduce Fibrogenic Markers, and Induce Utrophin Expression in Human DMD Myoblasts
por: Salvadori, Laura, et al.
Publicado: (2021)

Alternative utrophin mRNAs contribute to phenotypic differences between dystrophin‐deficient mice and Duchenne muscular dystrophy
por: Perkins, Kelly J., et al.
Publicado: (2018)

Utrophin Up-Regulation by an Artificial Transcription Factor in Transgenic Mice
por: Mattei, Elisabetta, et al.
Publicado: (2007)

Non-uniform dystrophin re-expression after CRISPR-mediated exon excision in the dystrophin/utrophin double-knockout mouse model of DMD
por: Hanson, Britt, et al.
Publicado: (2022)

Safety, Tolerability, and Pharmacokinetics of SMT C1100, a 2-Arylbenzoxazole Utrophin Modulator, following Single- and Multiple-Dose Administration to Pediatric Patients with Duchenne Muscular Dystrophy
por: Ricotti, Valeria, et al.
Publicado: (2016)

Sticky utrophin messages
por: Wells, William A.
Publicado: (2001)

The Cellular Processing Capacity Limits the Amounts of Chimeric U7 snRNA Available for Antisense Delivery
por: Eckenfelder, Agathe, et al.
Publicado: (2012)

Temporal transcriptomics suggest that twin-peaking genes reset the clock
por: Pembroke, William G, et al.
Publicado: (2015)

DMD & BMD – CLINICAL: P.51 DMD Hub: demonstrating impact for DMD trials
por: Heslop, E., et al.
Publicado: (2020)

PMO-based let-7c site blocking oligonucleotide (SBO) mediated utrophin upregulation in mdx mice, a therapeutic approach for Duchenne muscular dystrophy (DMD)
por: Sengupta, Kasturi, et al.
Publicado: (2020)

Utrophin gets a new look
por: Dove, Alan W.
Publicado: (2002)

Translational Regulation of Utrophin by miRNAs
por: Basu, Utpal, et al.
Publicado: (2011)

Utrophin Compensates dystrophin Loss during Mouse Spermatogenesis
por: Chen, Hung-Chih, et al.
Publicado: (2017)

Subtle Neuromuscular Defects in Utrophin-deficient Mice
por: Grady, R. Mark, et al.
Publicado: (1997)

Altered sodium channel function in dystrophin/utrophin-deficient cardiomyocytes
por: Koenig, Xaver, et al.
Publicado: (2010)

Functional Substitution by TAT-Utrophin in Dystrophin-Deficient Mice
por: Sonnemann, Kevin J., et al.
Publicado: (2009)

Muscle Structure Influences Utrophin Expression in mdx Mice
por: Banks, Glen B., et al.
Publicado: (2014)

Utrophin ABD binds to F-actin in an open conformation
por: Broderick, Mike J.F., et al.
Publicado: (2012)

Repression-free utrophin-A 5’UTR variants
por: Malik, Debasish, et al.
Publicado: (2019)

Regenerative biomarkers for Duchenne muscular dystrophy
por: Guiraud, Simon, et al.
Publicado: (2019)

Sarcospan reduces dystrophic pathology: stabilization of the utrophin–glycoprotein complex
por: Peter, Angela K., et al.
Publicado: (2008)

Distinct mechanical properties in homologous spectrin-like repeats of utrophin
por: Rajaganapathy, Sivaraman, et al.
Publicado: (2019)

UtroUp is a novel six zinc finger artificial transcription factor that recognises 18 base pairs of the utrophin promoter and efficiently drives utrophin upregulation
por: Onori, Annalisa, et al.
Publicado: (2013)

Exon skipping for DMD
por: Aartsma-Rus, Annemieke, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ct3jebk9eqqvhc8hgvu4v76iat